Incepta BioScience

About Us

Incepta BioScience functions as a division of Incepta Pharmaceuticals Ltd., specializing in the production of FDA - approved oral solid products. The facility has been purposefully designed to adhere to current Good Manufacturing Practices (cGMP) and meet international regulatory requirements, specifically those set by the US Food and Drug Administration (USFDA).

Incepta BioScience Facility Building

Operations and management at Incepta BioScience are autonomously controlled, ensuring a streamlined manufacturing process. A robust Quality System has been established to ensure compliance with all USFDA regulations regarding the manufacturing, packaging, and testing of oral solid products, including both New Drug Applications (NDA) and Abbreviated New Drug Applications (ANDA).

Continuous improvement is a key focus at Incepta BioScience. Areas for enhancement, such as quality attributes, process technology, and other technical aspects, are systematically identified and prioritized. By pursuing ongoing improvement, the aim is to elevate the overall quality of end products and deepen the understanding of manufacturing processes.

Incepta BioScience strives to manufacture oral solid products with the utmost care, precision, and compliance. A dedicated team of experts ensures that every product leaving the facility meets the highest industry standards, ensuring safety, efficacy, and patient satisfaction.